Bengaluru Uncovers Rs 5 Crore Fake Medicine Racket, SIT Probes Dubai Link

Context mode is active. Hover over any highlighted term to see its definition. Click a nested term to go deeper.
Bengaluru is reeling from a massive crackdown today as authorities unearthed an illegal repacking unit, seizing fake and expired medicines worth nearly Rs 5 crore. This bold operation, spearheaded by the Karnataka Food Safety and Drug Administration Drug Enforcement Wing, has exposed a sophisticated, alleged interstate and potentially international pharmaceutical racket, pushing critically ill patients at severe risk. The raid near Bidadi, which led to four arrests, uncovered cheaper medicines being relabeled to mimic expensive brands, including those from multinational pharmaceutical companies like Pfizer. This follows a significant Rs 9 crore anti-cancer drug bust in Delhi just days ago, highlighting a deeply rooted nationwide problem. The proliferation of such counterfeit drugs erodes public trust and poses an alarming public health crisis, with concerns that these harmful products may have already infiltrated hospitals and ICUs. The Karnataka government has now formed a Special Investigation Team (SIT), led by Joint Commissioner of Police C Vamsi Krishna, to dismantle this intricate network, which reportedly has links to Dubai. The SIT immediate focus will be to trace the full extent of this alleged racket, including its suppliers, distribution channels, and the suspected kingpin, R Prashanth, reportedly operating from Dubai. This incident escalates pressure on drug regulatory bodies across India, including the Central Drugs Standard Control Organisation (CDSCO), to intensify surveillance, improve pharmaceutical supply chain integrity, and enforce stricter penalties under the Drugs and Cosmetics Act, 1940, to prevent such life-threatening fraud. Expect heightened scrutiny on pharmacies and wholesalers, with calls for robust traceability systems and swift prosecution to safeguard patient lives.